Acquisition Announced

MiMedx Group acquisition of Sanara MedTech

US$350m enterprise value

Announced 29 Jul 2026 · NASDAQ: SMTI · US$35.00 cash and scrip per share · 46% premium

Advisers

Sanara MedTech

Target

Financial adviser
Legal adviser
Fairness opinion

MiMedx Group

Acquirer

Financial adviser
Legal adviser
Target
Sanara MedTech
Acquirer
MiMedx Group
Target based in
United States
Buyer based in
United States
Sector
Medtech

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.